Vilanterol
Vilanterol is a long-acting beta-2 adrenergic agonist (LABA) with ultra-long duration of action (>24 hours) that activates beta-2 receptors in bronchial smooth muscle, producing sustained bronchodilation through cAMP-mediated relaxation. It is used exclusively in combination with inhaled corticosteroids (fluticasone furoate) or as a dual bronchodilator (with umeclidinium) for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Its 24-hour duration enables once-daily dosing.
분자량
486.4000 g/mol
LogP
3.80
TPSA
91.20 Ų
리핀스키 5의 법칙
통과
치료 영역
Pharmacokinetics (PK)
Pharmacodynamics (PD)
2D 구조
Cite this structure
Embed this structure
SMILES
OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O
InChI
InChI=1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2/t24-/m0/s1
Molecular Formula
C24H33Cl2NO5
HBD / HBA
4 / 6
회전 가능 결합
16
무거운 원자
32
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
자주 묻는 질문
Vilanterol is a long-acting beta-2 adrenergic agonist (LABA) with ultra-long duration of action (>24 hours) that activates beta-2 receptors in bronchial smooth muscle, producing sustained bronchodilation through cAMP-mediated relaxation. It is used exclusively in combination with inhaled corticosteroids (fluticasone furoate) or as a dual bronchodilator (with umeclidinium) for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Its 24-hour duration enables once-daily dosing.
Yes, Vilanterol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1198857. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 10184665. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="vilanterol"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/vilanterol/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/vilanterol/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/vilanterol/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="vilanterol"></drugfyi-drug>